Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
92,360
-
Share change
-
-12,127
-
Total reported value
-
$86,089
-
Price per share
-
$0.94
-
Number of holders
-
8
-
Value change
-
-$35,161
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q1 2025
As of 31 Mar 2025,
Allarity Therapeutics, Inc. - COM (ALLR) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,360 shares.
The largest 9 holders included
GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, CORSAIR CAPITAL MANAGEMENT, L.P., BARCLAYS PLC, Tower Research Capital LLC (TRC), UBS Group AG, BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., and DANSKE BANK A/S.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.